Senseonics Holdings (SENS +7.8%) is up in early trade in response to Humana’s decision to cover its Eversense CGM (continue glucose monitor) System and insertion procedure for both type 1 and type 2 diabetics.
https://seekingalpha.com/news/3509722-senseonics-8-percent-humana-coverage-eversense
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.